GSK2239633

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK2239633, covering 2017-07-18 to 2017-07-18. Get the full timeline:

Most recent: Clinical Trial Update: Intravenous Microdose Pharmacokinetic (PK) Study With [14C]-GSK2239633 [Phase 1]